Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Main Street Research LLC

Main Street Research LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 80,238 shares of the medical equipment provider's stock after buying an additional 707 shares during the quarter. Intuitive Surgical comprises approximately 2.6% of Main Street Research LLC's holdings, making the stock its 16th largest holding. Main Street Research LLC's holdings in Intuitive Surgical were worth $39,739,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Chilton Capital Management LLC raised its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. Global Financial Private Client LLC raised its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares in the last quarter. Finally, Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the first quarter valued at about $26,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Down 2.7%

Intuitive Surgical stock traded down $13.99 during midday trading on Friday, reaching $512.06. 2,951,229 shares of the stock traded hands, compared to its average volume of 1,679,961. The company has a 50-day simple moving average of $538.20 and a two-hundred day simple moving average of $536.86. The firm has a market cap of $183.53 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 5.58 and a beta of 1.64. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the business posted $1.50 EPS. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Evercore ISI lifted their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price objective for the company from $515.00 to $440.00 in a report on Monday, June 9th. Truist Financial decreased their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Citigroup restated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Piper Sandler cut their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $592.59.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.